Atlas Trials

A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of ONO-2808-01 in Healthy Participants

Clinical trial NCT04578028 · COMPLETED

Trial details

NCT number
NCT04578028
Sponsor
Ono Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neurodegenerative Diseases
Start date
2020-08-19
Primary completion
2021-08-26
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.